Naquasone 0.55 mg (Dexamethasone Acetate SOLUTION) 0.55 MG

Naquasone 0.55 mg is a dexamethasone acetate solution for intramuscular use. This corticosteroid is commonly used for anti-inflammatory and immunosuppressive purposes in veterinary medicine.

Strength

0.55 MG

Pack Size

100ML

Manufacturer / TM Owner

INTERVET CANADA CORP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Naquasone 0.55 mg is primarily used for its anti-inflammatory and immunosuppressive properties. It is often administered to reduce swelling, pain, and allergic reactions in animals. Veterinarians may prescribe this medication for conditions that require rapid relief from inflammation or to suppress the immune system in certain diseases.

Side Effects

Common effects of Naquasone 0.55 mg may include reduced inflammation and pain relief. Some animals may experience temporary side effects such as increased thirst, increased appetite, or changes in behavior. Always monitor your pet closely after administration.

Precautions & Warnings

Naquasone 0.55 mg should be handled with care and stored as directed. It is important to follow your veterinarian's instructions for proper administration. Do not use this medication if your pet is allergic to dexamethasone or any of its components. Inform your veterinarian about any other medications your pet is taking.

Avoid Interactions

Naquasone 0.55 mg may interact with other medications, including certain antibiotics, antifungals, and immunosuppressants. It is important to discuss all current medications with your veterinarian to avoid potential interactions. Always follow your veterinarian's advice regarding the use of this medication.

Frequently Asked Questions

Naquasone 0.55 mg is used for its anti-inflammatory and immunosuppressive properties in veterinary medicine.

Naquasone 0.55 mg is administered intramuscularly. Follow your veterinarian's instructions for proper dosage and administration.

Common side effects may include increased thirst, increased appetite, or changes in behavior. Monitor your pet closely after administration.

Naquasone 0.55 mg may interact with other medications. Consult your veterinarian before combining it with other treatments.

Naquasone 0.55 mg can be purchased from authorized veterinary suppliers or online pharmacies that specialize in veterinary medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.